Global experts aim to use phage therapy to fight antibiotic resistance

As antibiotic resistance emerges as a global health crisis, scientists are revisiting an ancient, microscopic solution: phage therapy.

Bacteriophages, or simply 'phages,' are naturally occurring viruses that hunt and destroy specific bacteria.

Unlike traditional antibiotics that act like a blunt instrument, killing both harmful and helpful bacteria, phages are precision tools.

They selectively target specific pathogens, leaving the body's healthy microbiome intact.

This targeted approach is gaining momentum as the efficacy of conventional antibiotics declines.

Historically sidelined in the West, phage therapy is seeing a renaissance.

From success stories in personalized clinical cases to the establishment of national phage banks in countries like Belgium, experts are transforming these viruses into modern medical treatments.

While challenges remain—including navigating complex regulatory landscapes and optimizing how these therapies are delivered to infection sites—innovation is moving fast.

By transitioning from a 'last resort' to a proactive component of precision medicine, phage therapy offers a hopeful, evolutionary counter-move in our ongoing fight against superbugs.